Positions
- Letter regarding tobacco related issues in final FY 25 Appropriations Bills
- Letters requesting funding for CDC’s Office on Smoking and Health (OSH)
- SRNT’s FDA Nicotine Standard Docket Submission
- Coalition Docket Submission on the Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products
- SRNT Position on E-Cigarettes
- SRNT Letter to NCI re Funding of Nicotine and Tobacco Research
- Letter Urging FDA to take action on Synthetic Nicotine Tobacco Products
- Letter Urging Funding of CDC’s Office of Smoking and Health
- Senate Letter Opposing Bill to Exempt Some Cigars from FDA Oversight
- House Letter Opposing Bill to Exempt Some Cigars from FDA Oversight
- Letter to MLB and MLBPA to Prohibit use of Tobacco Products at MLB Stadiums
- Letter in Support of Smoke-Free VHA Legislation
- Letter to FDA re Youth Tobacco Cessation: Science and Treatment Strategies
- Letter to HHS re LGBT Discrimination and Healthcare Rights
- Letter to Representative Pallone re Reversing the Youth Tobacco Epidemic Act of 2019 That Would Prohibit the Sale of Menthol Cigarettes
- Letters to the US House and Senate re CDC and FDA FY20 Appropriation Issues
- SRNT Position on Binary Gender Definition, November 2018
- Letter re FY 2019 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill
- Letter re FY 2019 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations Bill
- Submission to Docket No. FDA-2017-N-6189 for Tobacco Product Standard for Nicotine Level of Certain Tobacco Products
- SRNT Comments on FDA’s Proposed Product Standard for NNN in Smokeless Tobacco Products
- Letter re Enforcing the Regulatory Reform Agenda under Executive Order 13777
- Letter re Renegotiation of NAFTA
- Letter in support of continued funding for the CDC Office of Smoking and Health #2
- Letter in support of continued funding for the CDC Office of Smoking and Health #1
- Letter re user fees for the Food and Drug Administration’s oversight of tobacco products #2
- Letter re user fees for the Food and Drug Administration’s oversight of tobacco products #1
- Letter in support of H.R. 1662, which would make facilities of the Veterans Health Administration (VHA) smoke-free
- Letter re 2017 US Federal appropriation bills an the weakening of FDA’s authority to oversee tobacco products
- Letter in opposition to S. 294 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA)
- Letter in opposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act
- Letter in Support of H.R. 1662, Making VHA Facilities Smoke-Free
- FY17 Finalizing Appropriations – House and Senate, April 2017
- SRNT Statement on the Administration’s Budget Blueprint
- Letter opposing H.R. 1136, the FDA Deeming Authority Clarification Act of 2017
- Letter to Blue Ribbon Panel on RFI for Developing the National Cancer Moonshot Initiative, July 2016
- FY17 Letter to House Appropriations – Ag Bill Markup, April 2016
- FY17 Letter to House Appropriations – FDA, April 2016
- FY17 Letter to House Appropriations – CDC OSH, April 2016
- FY17 Letter to Senate Appropriations – FDA, April 2016
- FY17 Letter to Senate Appropriations – CDC OSH, April 2016
- Coalition Letter on New Tobacco Products, February 2016
- Letter to the House and Senate in Support of the Tobacco Control Measure in TPP, February 2016
- SRNT Joint Comment on Investigational Tobacco Products Draft Guidance, November 2015
- SRNT Input on OBSSR Strategic Plan
- SRNT APA Petition Letter, November 2015
- SRNT Comment on ANPRM, September 2015
- Coalition Letter on House Appropriations Issues, September 2015
- Letter to FDA on American Spirit Marketing, August 2015
- Public Health Letter to the USTR, July 2015
- USPSTF Recommendation on Tobacco Cessation, June 2015
- Language to Change “Grandfather Date” in the House Agriculture Appropriations Bill, June 2015
- Request for the Obama Administration to Finalize Deeming Regulation, April 2015
- Brief of Amici Curiae Public Health Groups, March 2015
- Representation of Consent to File Amici Curiae Brief, March 2015
- SRNT Joint Letter to FDA on Tobacco, February 2015
- Letter to HHS and OIRA, February 2015
- SRNT Comment on NIDA Strategic Plan, January 2015
- Public Health Letter to HHS, January 2015
- SRNT Ariva Response, October 14, 2002
- FDA petition to regulate SF Garrett’s Nicotine Water, April 23, 2002
- FDA petition to regulate Omni and Advance Cigarettes, April 23, 2002
- Petition to the FDA to regulate Ariva tobacco lozenges, April 23, 2002
- Comments on the Prevention, Identification and Treatment Of Co-Occurring Disorders For SAMHSA, March 26, 2002
- SRNT Comment on National Cancer Institute Monograph, November 13, 2001
- Policy Statement, September 10, 2001
- Letter to the President, September 9, 2001
- Urging the FTC to maintain annual reports on sales, advertising and promotion of tobacco products, June 6, 2001
- Urging the FDA to review Eclipse, March 2001
- Urging the FTC to review Eclipse, March 2001